Spots Global Cancer Trial Database for rituximab and lenalidomide treatment
Every month we try and update this database with for rituximab and lenalidomide treatment cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma | NCT01476787 | Follicular Lymp... | Rituximab Lenalidomide Rituximab-CHOP Rituximab-CVP Rituximab-Benda... | 18 Years - | Celgene | |
A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma | NCT01650701 | Follicular Lymp... | Rituximab Lenalidomide Rituximab - CHO... Rituximab - CVP Rituximab - Ben... | 18 Years - | The Lymphoma Academic Research Organisation | |
A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma | NCT01650701 | Follicular Lymp... | Rituximab Lenalidomide Rituximab - CHO... Rituximab - CVP Rituximab - Ben... | 18 Years - | The Lymphoma Academic Research Organisation | |
A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma | NCT01650701 | Follicular Lymp... | Rituximab Lenalidomide Rituximab - CHO... Rituximab - CVP Rituximab - Ben... | 18 Years - | The Lymphoma Academic Research Organisation |